Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vincent Leroy

Showing results (101-110 of 172) with videos related to

Pageof 18
Sort By:
Journal of Hepatology|December 3, 2014
An extension of STARD statements for reporting diagnostic accuracy studies on liver fibrosis tests: the Liver-FibroSTARD standardsJérôme Boursier, Victor de Ledinghen, Thierry Poynard, et al.
Presse Medicale (Paris, France : 1983)|November 19, 2023
The liver in sickle cell diseaseChristophe Duvoux, Lorraine Blaise, Jean-Jacques Matimbo, et al.
Journal of Hepatology|September 3, 2013
Safety and efficacy of protease inhibitors to treat hepatitis C after liver transplantation: a multicenter experienceAudrey Coilly, Bruno Roche, Jérôme Dumortier, et al.
Gastroenterology|June 25, 2011
A poxvirus vaccine is safe, induces T-cell responses, and decreases viral load in patients with chronic hepatitis CFrançois Habersetzer, Géraldine Honnet, Christine Bain, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|April 16, 2018
Effectiveness and safety of anti-TNF therapy for inflammatory bowel disease in liver transplant recipients for primary sclerosing cholangitis: A nationwide case seriesRomain Altwegg, Roman Combes, David Laharie, et al.
Antiviral Therapy|July 22, 2017
Baseline and post-treatment hepatitis C NS5A resistance in relapsed patients from a multicentric real-life cohortPhilippe Halfon, Caroline Scholtès, Jacques Izopet, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 6, 2015
Efficacy of Sofosbuvir and Daclatasvir in Patients With Fibrosing Cholestatic Hepatitis C After Liver TransplantationVincent Leroy, Jérôme Dumortier, Audrey Coilly, et al.
Gastroenterology|March 29, 2011
High-dose pegylated interferon-α and ribavirin in nonresponder hepatitis C patients and relationship with IL-28B genotype (SYREN trial)Stéphane Chevaliez, Christophe Hézode, Alexandre Soulier, et al.
Hepatology Communications|June 27, 2024
Selective internal radiation therapy for unresectable HCC: The SIRT downstaging studyHélène Regnault, Julia Chalaye, Athena Galetto-Pregliasco, et al.
European Journal of Gastroenterology & Hepatology|December 23, 2017
Efficacy of daclatasvir-based quadruple therapy in nonresponder patients infected by hepatitis C virus genotype 4: the ANRS HC32 QUATTRO studyDominique Roulot, Vincent Thibault, Claire Laforest, et al.
Pageof 18

Showing results (101-110 of 172) with videos related to

Sort By:
Pageof 18
Journal of Hepatology|December 3, 2014
An extension of STARD statements for reporting diagnostic accuracy studies on liver fibrosis tests: the Liver-FibroSTARD standardsJérôme Boursier, Victor de Ledinghen, Thierry Poynard, et al.
Presse Medicale (Paris, France : 1983)|November 19, 2023
The liver in sickle cell diseaseChristophe Duvoux, Lorraine Blaise, Jean-Jacques Matimbo, et al.
Journal of Hepatology|September 3, 2013
Safety and efficacy of protease inhibitors to treat hepatitis C after liver transplantation: a multicenter experienceAudrey Coilly, Bruno Roche, Jérôme Dumortier, et al.
Gastroenterology|June 25, 2011
A poxvirus vaccine is safe, induces T-cell responses, and decreases viral load in patients with chronic hepatitis CFrançois Habersetzer, Géraldine Honnet, Christine Bain, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|April 16, 2018
Effectiveness and safety of anti-TNF therapy for inflammatory bowel disease in liver transplant recipients for primary sclerosing cholangitis: A nationwide case seriesRomain Altwegg, Roman Combes, David Laharie, et al.
Antiviral Therapy|July 22, 2017
Baseline and post-treatment hepatitis C NS5A resistance in relapsed patients from a multicentric real-life cohortPhilippe Halfon, Caroline Scholtès, Jacques Izopet, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 6, 2015
Efficacy of Sofosbuvir and Daclatasvir in Patients With Fibrosing Cholestatic Hepatitis C After Liver TransplantationVincent Leroy, Jérôme Dumortier, Audrey Coilly, et al.
Gastroenterology|March 29, 2011
High-dose pegylated interferon-α and ribavirin in nonresponder hepatitis C patients and relationship with IL-28B genotype (SYREN trial)Stéphane Chevaliez, Christophe Hézode, Alexandre Soulier, et al.
Hepatology Communications|June 27, 2024
Selective internal radiation therapy for unresectable HCC: The SIRT downstaging studyHélène Regnault, Julia Chalaye, Athena Galetto-Pregliasco, et al.
European Journal of Gastroenterology & Hepatology|December 23, 2017
Efficacy of daclatasvir-based quadruple therapy in nonresponder patients infected by hepatitis C virus genotype 4: the ANRS HC32 QUATTRO studyDominique Roulot, Vincent Thibault, Claire Laforest, et al.
Pageof 18